• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在最近的抗逆转录病毒治疗时代,艾滋病毒感染、人口统计学和心血管危险因素与全因死亡率的关系。

Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

机构信息

Department of Medicine, University of California, San Francisco, CA, USA.

出版信息

J Acquir Immune Defic Syndr. 2010 Jan;53(1):102-6. doi: 10.1097/QAI.0b013e3181b79d22.

DOI:10.1097/QAI.0b013e3181b79d22
PMID:19738484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2799541/
Abstract

OBJECTIVE

To determine the relationship of HIV infection, demographic, and cardiovascular disease (CVD) risk factors with mortality in the recent highly active antiretroviral therapy era.

METHODS

Vital status was ascertained from 2004 to 2007 in 922 HIV infected and 280 controls in the Study of Fat Redistribution and Metabolic Change in HIV infection; 469 HIV infected were included in analysis comparing HIV with similar age controls. Multivariable exponential survival regression (adjusting for demographic and CVD factors) estimated hazard ratios (HRs) for death.

RESULTS

After 5 years of follow-up, the overall adjusted mortality HR was 3.4 [95% confidence interval (CI): 1.35-8.5]; HR was 6.3 among HIV infected with CD4 < 200 (95% CI: 2.2-18.2), 4.3 with CD4 200-350 (95% CI: 1.14-16.0), and 2.3 with CD4 > 350 (95% CI: 0.78-6.9). Among HIV infected, current smoking (HR = 2.73 vs. never smokers, 95% CI: 1.64-4.5) and older age (HR = 1.61 per decade, 95% CI: 1.27-2.1) were independent risk factors for death; higher baseline CD4 count was associated with lower risk (HR = 0.65 per CD4 doubling, 95% CI: 0.58-0.73).

CONCLUSIONS

HIV infection was associated with a 3-fold mortality risk compared with controls after adjustment for demographic and CVD risk factors. In addition to low baseline CD4 count, older age and current smoking were strong and independent predictors of mortality in a US cohort of HIV-infected participants in clinical care.

摘要

目的

在近期高效抗逆转录病毒治疗时代,确定 HIV 感染、人口统计学和心血管疾病(CVD)危险因素与死亡率的关系。

方法

在 HIV 感染的脂肪重新分布和代谢变化研究中,从 2004 年到 2007 年确定了 922 名 HIV 感染者和 280 名对照者的存活状况;在比较 HIV 与年龄相似的对照者的分析中,纳入了 469 名 HIV 感染者。多变量指数生存回归(调整人口统计学和 CVD 因素)估计了死亡的风险比(HR)。

结果

在 5 年的随访后,总体调整后的死亡率 HR 为 3.4 [95%置信区间(CI):1.35-8.5];CD4<200 的 HIV 感染者 HR 为 6.3(95% CI:2.2-18.2),CD4 200-350 的 HIV 感染者 HR 为 4.3(95% CI:1.14-16.0),CD4>350 的 HIV 感染者 HR 为 2.3(95% CI:0.78-6.9)。在 HIV 感染者中,当前吸烟(HR=2.73 比从不吸烟者,95% CI:1.64-4.5)和年龄较大(每增加十年 HR=1.61,95% CI:1.27-2.1)是死亡的独立危险因素;较高的基线 CD4 计数与较低的风险相关(HR=每增加 CD4 翻倍 0.65,95% CI:0.58-0.73)。

结论

在调整人口统计学和 CVD 危险因素后,与对照者相比,HIV 感染的死亡率风险增加了 3 倍。除了较低的基线 CD4 计数外,年龄较大和当前吸烟是美国 HIV 感染者临床护理队列死亡率的强有力和独立预测因素。

相似文献

1
Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.在最近的抗逆转录病毒治疗时代,艾滋病毒感染、人口统计学和心血管危险因素与全因死亡率的关系。
J Acquir Immune Defic Syndr. 2010 Jan;53(1):102-6. doi: 10.1097/QAI.0b013e3181b79d22.
2
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.与成人 HIV 感染者的非致命性 AIDS 和严重非 AIDS 事件相关的全因死亡率风险。
AIDS. 2010 Mar 13;24(5):697-706. doi: 10.1097/QAD.0b013e3283365356.
3
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.D:A:D 研究中 HIV 阳性个体特定死因相关因素。
AIDS. 2010 Jun 19;24(10):1537-48. doi: 10.1097/QAD.0b013e32833a0918.
4
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.抗逆转录病毒治疗时代 HIV-1 感染儿童死亡率的下降和死亡原因的变化。
J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94. doi: 10.1097/QAI.0b013e3181b9869f.
5
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代城市中感染艾滋病毒及有吸毒风险人群队列中的死亡率
Clin Infect Dis. 2005 Sep 15;41(6):864-72. doi: 10.1086/432883. Epub 2005 Aug 16.
6
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.当CD4+细胞计数为0.200至0.350×10⁹个细胞/升时,药物依从性对开始高效抗逆转录病毒治疗的HIV感染成人患者生存的影响。
Ann Intern Med. 2003 Nov 18;139(10):810-6. doi: 10.7326/0003-4819-139-10-200311180-00008.
7
Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.接受治疗的HIV感染者在抗逆转录病毒治疗使用情况及死亡率方面的种族和性别差异。
J Infect Dis. 2009 Apr 1;199(7):991-8. doi: 10.1086/597124.
8
Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.尽管接受了高效抗逆转录病毒治疗,公共保险参与者在 HIV 门诊研究中的死亡率仍升高。
AIDS. 2011 Sep 24;25(15):1865-76. doi: 10.1097/QAD.0b013e32834b3537.
9
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.开始接受高效抗逆转录病毒治疗(HAART)且CD4 + T细胞计数≥200个细胞/立方毫米的HIV-1阳性患者临床进展的预测因素。
Antivir Ther. 2007;12(6):941-7.
10
Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.美国队列中 HIV-1 感染女性产后中断抗逆转录病毒治疗与艾滋病相关定义事件、非艾滋病相关定义事件和死亡率的关系。
AIDS Patient Care STDS. 2010 May;24(5):279-86. doi: 10.1089/apc.2009.0283.

引用本文的文献

1
Plasma lipidomic alterations during pathogenic SIV infection with and without antiretroviral therapy.致病性猴免疫缺陷病毒感染期间,接受和未接受抗逆转录病毒治疗时的血浆脂质组学改变。
Front Immunol. 2025 Mar 10;16:1475160. doi: 10.3389/fimmu.2025.1475160. eCollection 2025.
2
Patterns and prognosis of holding regimens for people living with HIV in Asian countries.亚洲国家艾滋病毒感染者维持治疗方案的模式和预后。
PLoS One. 2022 Mar 30;17(3):e0264157. doi: 10.1371/journal.pone.0264157. eCollection 2022.
3
Trends of HIV-Related Cancer Mortality between 2001 and 2018: An Observational Analysis.2001年至2018年期间与艾滋病病毒相关的癌症死亡率趋势:一项观察性分析。
Trop Med Infect Dis. 2021 Dec 20;6(4):213. doi: 10.3390/tropicalmed6040213.
4
Altered Lipid Profiles and Vaccine Induced-Humoral Responses in Children Living With HIV on Antiretroviral Therapy in Tanzania.坦桑尼亚接受抗逆转录病毒疗法的 HIV 患儿的脂质谱变化和疫苗诱导的体液免疫反应。
Front Cell Infect Microbiol. 2021 Nov 9;11:721747. doi: 10.3389/fcimb.2021.721747. eCollection 2021.
5
Trends of HIV Mortality between 2001 and 2018: An Observational Analysis.2001年至2018年期间艾滋病毒死亡率趋势:一项观察性分析。
Trop Med Infect Dis. 2021 Sep 24;6(4):173. doi: 10.3390/tropicalmed6040173.
6
Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review.艾滋病毒感染者中心血管代谢综合征的患病率:一项系统综述。
J Diabetes Metab Disord. 2020 Jun 9;19(2):1671-1683. doi: 10.1007/s40200-020-00552-x. eCollection 2020 Dec.
7
Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV.围生期获得性 HIV 感染儿童的生物学衰老与免疫衰老。
J Immunol Res. 2020 May 16;2020:8041616. doi: 10.1155/2020/8041616. eCollection 2020.
8
Early Versus Delayed Mortality among HIV Infected Patients Initiating Highly Active Antiretroviral Therapy in Tanzania.坦桑尼亚开始接受高效抗逆转录病毒治疗的艾滋病毒感染患者的早期与延迟死亡率
J Res Appl Sci. 2016;3(1):178-185.
9
HIV-Related Stigmatization and Medication Adherence: Indirect Effects of Disclosure Concerns and Depression.与艾滋病病毒相关的污名化与药物依从性:披露担忧和抑郁的间接影响
Stigma Health. 2019 Aug;4(3):282-292. doi: 10.1037/sah0000144. Epub 2018 May 14.
10
A qualitative study of the feasibility and acceptability of a smoking cessation program for people living with HIV and emotional dysregulation.一项关于针对感染艾滋病毒且情绪失调者戒烟计划的可行性和可接受性的定性研究。
AIDS Care. 2019 May;31(5):609-615. doi: 10.1080/09540121.2018.1533225. Epub 2018 Oct 23.

本文引用的文献

1
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.人类免疫缺陷病毒(HIV)引起的免疫缺陷以及由艾滋病界定和非艾滋病界定的恶性肿瘤导致的死亡率。
AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77.
2
Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).2000年至2005年间感染艾滋病毒的成年人死亡原因的变化:“2000年和2005年死亡率”调查(法国国家艾滋病研究机构EN19和Mortavic研究)
J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8. doi: 10.1097/QAI.0b013e31817efb54.
3
Changes in the risk of death after HIV seroconversion compared with mortality in the general population.与普通人群死亡率相比,HIV血清转化后死亡风险的变化。
JAMA. 2008 Jul 2;300(1):51-9. doi: 10.1001/jama.300.1.51.
4
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.接受长期联合抗逆转录病毒治疗且CD4细胞计数大于500个细胞/立方毫米的HIV感染成人的死亡率与普通人群相同。
J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):72-7. doi: 10.1097/QAI.0b013e318134257a.
5
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.接受高效抗逆转录病毒治疗的艾滋病毒感染者的发病率和死亡率与来自相同地理区域的相似年龄普通人群的估计值相比较。
HIV Med. 2007 May;8(4):251-8. doi: 10.1111/j.1468-1293.2007.00468.x.
6
Survival of persons with and without HIV infection in Denmark, 1995-2005.1995 - 2005年丹麦有和没有感染艾滋病毒者的生存率。
Ann Intern Med. 2007 Jan 16;146(2):87-95. doi: 10.7326/0003-4819-146-2-200701160-00003.
7
CD4+ count-guided interruption of antiretroviral treatment.基于CD4细胞计数指导的抗逆转录病毒治疗中断
N Engl J Med. 2006 Nov 30;355(22):2283-96. doi: 10.1056/NEJMoa062360.
8
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.高效抗逆转录病毒治疗时代的死亡率:HIV门诊研究中死亡和疾病原因的变化
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34. doi: 10.1097/01.qai.0000233310.90484.16.
9
The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.HIV感染中脂肪重新分布和代谢变化的研究(FRAM):方法、设计及样本特征
Am J Epidemiol. 2006 May 1;163(9):860-9. doi: 10.1093/aje/kwj111. Epub 2006 Mar 8.
10
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.HIV感染者的死因及死亡率比较:高效抗逆转录病毒治疗前、早期和晚期阶段的分析
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200. doi: 10.1097/01.qai.0000179459.31562.16.